These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28874103)

  • 21. Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.
    Rondanelli M; Perna S; Faliva M; Monteferrario F; Repaci E; Allieri F
    Arch Gynecol Obstet; 2014 Dec; 290(6):1079-92. PubMed ID: 25200687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of obesity and polycystic ovary syndrome in adolescents.
    Vilmann LS; Thisted E; Baker JL; Holm JC
    Horm Res Paediatr; 2012; 78(5-6):269-78. PubMed ID: 23208318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects.
    Palioura E; Kandaraki E; Diamanti-Kandarakis E
    Horm Mol Biol Clin Investig; 2014 Mar; 17(3):137-44. PubMed ID: 25372737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome.
    Carmina E
    Front Horm Res; 2013; 40():40-50. PubMed ID: 24002404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
    Mayer SB; Evans WS; Nestler JE
    Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.
    Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ
    Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New markers of insulin resistance in polycystic ovary syndrome.
    Polak K; Czyzyk A; Simoncini T; Meczekalski B
    J Endocrinol Invest; 2017 Jan; 40(1):1-8. PubMed ID: 27473078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of sympathetic nervous system activity with polycystic ovarian syndrome.
    Li W; Chen Y; Xu L
    Clin Exp Obstet Gynecol; 2014; 41(5):499-506. PubMed ID: 25864247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine and endocrine dysfunction in the hyperinsulinemic PCOS patient: the role of metformin.
    Weickert MO; Hodges P; Tan BK; Randeva HS
    Minerva Endocrinol; 2012 Mar; 37(1):25-40. PubMed ID: 22382613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.
    Garin MC; Butts SF; Sarwer DB; Allison KC; Senapati S; Dokras A
    Endocrine; 2017 Mar; 55(3):907-913. PubMed ID: 28004236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutritional management in women with polycystic ovary syndrome: A review study.
    Faghfoori Z; Fazelian S; Shadnoush M; Goodarzi R
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S429-S432. PubMed ID: 28416368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin.
    Osto M; Wielinga PY; Alder B; Walser N; Lutz TA
    Physiol Behav; 2007 Aug; 91(5):566-72. PubMed ID: 17481674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity and the polycystic ovary syndrome.
    Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine factors in the hypothalamic regulation of food intake in females: a review of the physiological roles and interactions of ghrelin, leptin, thyroid hormones, oestrogen and insulin.
    Somogyi V; Gyorffy A; Scalise TJ; Kiss DS; Goszleth G; Bartha T; Frenyo VL; Zsarnovszky A
    Nutr Res Rev; 2011 Jun; 24(1):132-54. PubMed ID: 21418732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role Of Vitamin D And Adipose Tissue Hormones In Women With Reproductive Disorders.
    Nyagolova PV; Mitkov MD; Orbetsova MM
    Folia Med (Plovdiv); 2015; 57(1):5-10. PubMed ID: 26431089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pro12Ala PPAR γ2 gene polymorphism in PCOS women: the role of compounds regulating satiety.
    Bidzińska-Speichert B; Lenarcik A; Tworowska-Bardzińska U; Slęzak R; Bednarek-Tupikowska G; Milewicz A
    Gynecol Endocrinol; 2012 Mar; 28(3):195-8. PubMed ID: 21827375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome.
    Chen CI; Hsu MI; Lin SH; Chang YC; Hsu CS; Tzeng CR
    Gynecol Endocrinol; 2015 Apr; 31(4):264-8. PubMed ID: 25423261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The etiopathogenetic hypotheses in polycystic ovary].
    Ghemigian A; Vulpoi C; Păun D; Preda C
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):49-55. PubMed ID: 10756770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycystic ovary syndrome and the metabolic syndrome.
    Weerakiet S
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hypothalamic-pituitary-adrenal axis in the neuroendocrine regulation of food intake and obesity: the role of corticotropin releasing hormone.
    Mastorakos G; Zapanti E
    Nutr Neurosci; 2004; 7(5-6):271-80. PubMed ID: 15682923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.